Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03468985
Brief Title: Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

First Submitted : March 13, 2018
First Submitted that Met QC Criteria : March 16, 2018
First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : June 8, 2021
Last Update Posted : June 9, 2021